Author:
Takehisa Hanawa,Naoko Endoh,Masahiko Suzuki,Katsuhide Terada,Moriyuki Ohkuma,Keizoh Sakuta,Mutsuko Tanaka,Kenji Kawano,Shin’ichiro Nakajima,Toshio Oguchi
Reference22 articles.
1. AdvaMed, 2001. 21-day repeat dose male reproductive tract study of di(2-ethylhexyl) phthalate (DEHP) administered either intravenously or orally to rats starting at neonatal age 3–5 days, with satellite recovery group through 90 days of age. Study number 11947.
2. Finite bath and boundary layer effects on solute release kinetics from solid matrices;Amarantos;J. Membr. Sci.,1987
3. Center for Devices and Radiological Health, U.S. Food and Drug Administration, 2001. Safety assessment of di(2-ethylhexyl) phthalate (DEHP) released from PVC medical devices. Table 4-1, Rockville, MD, USA.
4. Risk assessment of di(2-ethylhexyl)phthalate released from PBC blood circuits during hemodialysis and pump-oxygen therapy;Haishima;Int. J. Pharmaceut.,2004
5. Investigation of the release behavior of diethylhexyl phthalate from polyvinyl-chloride tubing for intravenous administration;Hanawa;Int. J. Pharmaceut.,2000
Cited by
58 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献